ClinicalTrials.Veeva

Menu

Pentacam Findings After Implantation of Intrastromal Corneal Rings in Keratoconus.

A

Assiut University

Status

Enrolling

Conditions

Keratoconus

Treatments

Device: corneal tomography scans

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

keratoconus is a progressive corneal ectatic disease characterized by paraxial stromal thinning and weakening, resulting in irregular astigmatism, corneal protrusion, and distortion of the anterior corneal surface. It is usually bilateral, although asymmetrical in most cases.

Intrastromal corneal rings are polymethylmethacrylate devices successfully used for the management of keratoconus, pellucid marginal degeneration, post-LASIK ectasia and myopia. Intrastromal corneal rings implantation is safe and reversible procedure that does not affect the central corneal area, and hence, avoids interference with visual axis. The goal of intrastromal corneal rings implantation is to improve visual acuity by regulariztion of the anterior corneal surface.

Enrollment

44 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Keratoconus grade I, II and III according to the mean K Amsler-Krumeich classification.
  • Contact lens intolerance.
  • Thinnest location is more than 400 um.
  • Maximum keratometry (Kmax) between 48 and 64 D.
  • Clear cornea with no Vogt's striae.

Exclusion criteria

  • Previous corneal surgery.
  • Grade IV with corneal scarring.
  • Concurrent corneal disease in addition to KC.
  • Autoimmune or systemic connective tissue diseases.

Trial design

44 participants in 1 patient group

keratoconus group
Description:
patients with keratoconus implanted with the Myoring 360 degree, KeraRing 355 degree, KeraRing one segment, KeraRing two segments ICRS .corneal tomography scans of the two corneal surfaces were obtained preoperatively and postoperatively with a rotating Scheimpflug imaging system .pentacam data that will be included
Treatment:
Device: corneal tomography scans

Trial contacts and locations

1

Loading...

Central trial contact

Hani Elsodafy, MD; Magdi M Mostafa, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems